Zurich Cantonal Bank’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Hold
0
2987
2022
Q1
Hold
0
2913
2021
Q4
Hold
0
2987
2021
Q3
Hold
0
2854
2021
Q2
Hold
0
2657
2021
Q1
Hold
0
2694
2020
Q4
Hold
0
2671
2020
Q3
Hold
0
2581
2020
Q2
Hold
0
2672
2020
Q1
Sell
-190
Closed -$7.09K 2627
2019
Q4
$8K Hold
190
﹤0.01% 2580
2019
Q3
$8K Hold
190
﹤0.01% 2578
2019
Q2
$11K Sell
190
-62
-25% -$5.97K ﹤0.01% 2565
2019
Q1
$31K Hold
252
﹤0.01% 2264
2018
Q4
$35K Sell
252
-60
-19% -$15.1K ﹤0.01% 2234
2018
Q3
$96K Hold
312
﹤0.01% 1734
2018
Q2
$95K Hold
312
﹤0.01% 1678
2018
Q1
$129K Sell
312
-107
-26% -$43.9K ﹤0.01% 1458
2017
Q4
$150K Hold
419
﹤0.01% 1353
2017
Q3
$88K Buy
+419
New +$93.4K ﹤0.01% 1473

Other funds holding ONCS

Zurich Cantonal Bank's ONCS Position: Q2 2022 in Review

Zurich Cantonal Bank held its OncoSec Medical Incorporated (ONCS) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

Zurich Cantonal Bank first reported a position in ONCS in Q3 2017 and has held it in 10 quarters since. The position peaked at $150K in Q4 2017. 25 funds tracked by Wall St. Rank hold ONCS as of Q2 2022.

  • Zurich Cantonal Bank held 0 shares of OncoSec Medical Incorporated worth $0 as of Q2 2022.
  • Zurich Cantonal Bank left its OncoSec Medical Incorporated share count unchanged in Q2 2022.
  • OncoSec Medical Incorporated made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2022, its #2987 holding.
  • Zurich Cantonal Bank first reported a position in OncoSec Medical Incorporated in Q3 2017 and has held it in 10 quarters since.
  • Zurich Cantonal Bank's OncoSec Medical Incorporated position peaked at $150K in Q4 2017.
  • 25 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.